Research Into the Genetic Component of Heart Disease: From Linkage Studies to Genome-Wide Genotyping;Estudio del componente genético de la cardiopatía isquémica: de los estudios de ligamiento al genotipado integral del genoma

Revista Espanola de Cardiologia Suplementos

Volumn 9, Issue 2, 2009, Pages 24-38

  Elosua, Roberto ^a,b   Lluis, Carla ^a   Lucas, Gavin ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Coronary heart disease; Genetic variants; Genetics; Polymorphisms

Indexed keywords

ARTICLE; GENE MUTATION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOME; GENOTYPE; ISCHEMIC HEART DISEASE; PHENOTYPE;

EID: 67649516363     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1131-3587(09)71502-X     Document Type: Article

References (135)

1. Sanger F., Nicklen S., and Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74 (1977) 5463-5467
2. Maxam A.M., and Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A 74 (1977) 560-564
3. Saiki R.K., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H.A., et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230 (1985) 1350-1354
4. International Human Genome Mapping Consortium. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
5. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
6. Online Mendelian Inheritance in Man. Disponible en: www.ncbi.nlm.nih.gov/sites/entrez?db=omim
7. Civeira F., and International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173 (2004) 55-68
8. Lehnart S.E., Ackerman M.J., Benson Jr. D.W., Brugada R., Clancy C.E., Donahue J.K., et al. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 116 (2007) 2325-2345
9. Sen-Chowdhry S., Syrris P., and McKenna W.J. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 50 (2007) 1813-1821
10. O'Donnel C.J., and Elosua R. Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study. Rev Esp Cardiol 61 (2008) 299-310
11. Murray C.J.L., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
12. Instituto Nacional de Estadística. Tablas de mortalidad de la población de España por Comunidades autónomas, Sexo, Edades, Años y Funciones [citado 30 Ene 2009]. Disponible en: http://www.ine.es/jaxi/menu.do?type=pcaxis&path=%2Ft 20%2Fp319a%2F1992-2005&file=pcaxis&N=&L=0
13. Marrugat J., Elosua R., and Marti H. Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005. Rev Esp Cardiol 55 (2002) 337-346
14. White P.D. The genes, the heart and destiny. N Engl J Med 256 (1957) 965-969
15. Mayer B., Erdmann J., and Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol 96 (2007) 1-7
16. Thomas C.B., and Cohen H.B. Familial ocurrence of hypertension and coronary artery disease, with observations concerning obesity and diabetes. Ann Int Med 42 (1955) 90-127
17. Lloyd-Jones D.M., Nam B.H., D'Agostino Sr. R.B., Levy D., Murabito J.M., Wang T.J., et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 291 (2004) 2204-2211
18. Murabito J.M., Pencina M.J., Nam B.H., D'Agostino Sr. R.B., Wang T.J., Lloyd-Jones D., et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 294 (2005) 3117-3123
19. Marenberg M.E., Risch N., Berkman L.F., et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
20. Deutscher S., Sepstein F.H., and Kjelsberg M.O. Familial aggregation of factors associated with coronary heart disease. Circulation 33 (1966) 911-924
21. Nora J.J., Lortscher R.H., Spangler R.D., Nora A.H., and Kimberling W.J. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 61 (1980) 503-508
22. Zdravkovic S., Wienke A., Pedersen N.L., Marenberg M.E., Yashin A.I., and De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 252 (2002) 247-254
23. Wienke A., Holm N.V., Skytthe A., and Yashin A.I. The heritability of mortality due to heart diseases: a correlated frailty model applied to Danish twins. Twin Res 4 (2001) 266-274
24. Peyser P.A., Bielak L.F., Chu J.S., Turner S.T., Ellsworth D.L., Boerwinkle E., et al. Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 106 (2002) 304-308
25. Xiang A.H., Azen S.P., Buchanan T.A., Raffel L.J., Tan S., Cheng L.S., et al. Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arterioscler Thromb Vasc Biol 22 (2002) 843-848
26. Fox C.S., Polak J.F., Chazaro I., Cupples A., Wolf P.A., D'Agostino R.A., et al. Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intima-media thickness in the Framingham Heart Study. Stroke 34 (2003) 397-401
27. Juo S.H., Lin H.F., Rundek T., Sabala E.A., Boden-Albala B., Park N., et al. Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study. Stroke 35 (2004) 2243-2247
28. Swan L., Birnie D.H., Inglis G., Connell J.M., and Hillis W.S. The determination of carotid intima medial thickness in adults-a population-based twin study. Atherosclerosis 166 (2003) 137-141
29. North K.E., MacCluer J.W., Devereux R.B., Howard B.V., Welty T.K., Best L.G., et al. Heritability of carotid artery structure and function: the Strong Heart Family Study. Arterioscler Thromb Vasc Biol 22 (2002) 1698-1703
30. Hunt K.J., Duggirala R., Göring H.H., Williams J.T., Almasy L., Blangero J., et al. Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study. Stroke 33 (2002) 2775-2780
31. Van Asselt K.M., Kok H.S., Van der Schouw Y.T., Peeters P.H.M., Pearson P.L., and Grobbee D.E. Role of genetic analyses in cardiology. Part II: Heritability estimation for gene searching in multifactorial diseases. Circulation 113 (2006) 1136-1139
32. Donis-Keller H., Green P., Helms C., Cartinhour S., Weiffenbach B., Stephens K., et al. A genetic linkage map of the human genome. Cell 51 (1987) 319
33. Gusella J.F., Wexler N.S., Conneally P.M., Naylor S.L., Anderson M.A., Tanzi R.E., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306 (1983) 234
34. Wang X., Ishimori N., Korstanje R., Rollins J., and Paigen B. Identifying novel genes for atherosclerosis through mousehuman comparative genetics. Am J Hum Genet 77 (2005) 1-15
35. Pajukanta P., Cargill M., Viitanen L., Nuotio I., Kareinen A., Perola M., et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet 67 (2000) 1481-1493
36. Francke S., Manraj M., Lacquemant C., Lecoeur C., Leprêtre F., Passa P., et al. A Genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 10 (2001) 2751-2765
37. Broeckel U., Hengstenberg C., Mayer B., Holmer S., Martin L.J., Comuzzie A.G., et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 30 (2002) 210-214
38. Wang L. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302 (2003) 1578-1581
39. Wang Q., Rao S., Shen G.Q., Li L., Moliterno D.J., Newby L.K., et al. Premature myocardial infarction novel susceptibility locus on chromosome 1p34-36 identified by genomewide linkage analysis. Am J Hum Genet 74 (2004) 262-271
40. Hauser E.R., Crossman D.C., Granger C.B., Haines J.L., Jones C.J., Mooser V., et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 75 (2004) 436-447
41. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., et al. The gene encoding 5-lipoxiygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36 (2004) 233-239
42. BHF Family Heart Study Research Group. A genomewide linkage study of 1933 families affected by premature coronary artery disease: the British Heart Foundation (BHF) Family Heart Study. Am J Hum Genet 77 (2005) 1011-1020
43. González P., García-Castro M., Reguero J.R., Batalla A., Ordóñez A.G., Palop R.L., et al. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J Med Genet 43 (2006) 167-169
44. Weng L., Kavaslar N., Ustaszewska A., Doelle H., Schackwitz W., Hébert S., et al. Lack of MEF2A mutations in coronary artery disease. J Clin Invest 115 (2005) 1016-1020
45. Lieb W., Mayer B., König I.R., Borwitzky I., Götz A., Kain S., et al. Lack of association between the MEF2A gene and myocardial infarction. Circulation 117 (2008) 185-191
46. Altshuler D., and Hirschhorn J.N. MEF2A sequence variants and coronary artery disease: a change of heart?. J Clin Invest 115 (2005) 831-833
47. Helgadottir A., Gretarsdottir S., St Clair D., Manolescu A., Cheung J., Thorleifsson G., et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 76 (2005) 505-509
48. Kaushal R., Pal P., Alwell K., Haverbusch M., Flaherty M., Moomaw C., et al. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum Genet 121 (2007) 601-607
49. Zee R.Y., Cheng S., Hegener H.H., Erlich H.A., and Ridker P.M. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 37 (2006) 2007-2011
50. Meharabian M., Allayee H., Wong J., et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91 (2002) 120-126
51. Hakonarson H., Thorvaldsson S., Helgadottir A., et al. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. JAMA 293 (2005) 2245-2256
52. Schulze T.G., and McMahon F.J. Genetic association mapping at the crossroads: which test and why? Overview and practical guidelines. Am J Med Genet 114 (2002) 1-11
53. Aird I., Bentall H.H., Mehigan J.A., and Roberts J.A. The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration. Br Med J 2 (1954) 315-321
54. Attia J., Ioannidis J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., et al. How to use an article about genetic association. A: Background concepts. JAMA 301 (2009) 74-81
55. Attia J., Ioannidis J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., et al. How to use an article about genetic association: B: Are the results of the study valid?. JAMA 301 (2009) 191-197
56. Attia J., Ioannidis J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., et al. How to use an article about genetic association: C: What are the results and will they help me in caring for my patients?. JAMA 301 (2009) 304-308
57. Hirschhorn J.N., Lohmueller K., Byrne E., and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61
58. Bennet A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298 (2007) 1300-1311
59. Ioannidis J.P. Why most discovered true associations are inflated. Epidemiology 19 (2008) 640-648
60. Ioannidis J.P. Why most published research findings are false. PloS Med 2 (2005) e124
61. Chanock S.J., Manolio T., Boehnke M., Boerwinkle E., Hunter D.J., Thomas G., et al. NCI-NHGRI Working Group on Replication in Association Studies. Replicating genotype-phenotype associations. Nature 447 (2007) 655-660
62. Ioannidis J.P., Boffetta P., Little J., O'Brien T.R., Uitterlinden A.G., Vineis P., et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37 (2008) 120-132
63. Cohen J., Pertsemlidis A., Kotowski I.K., Graham R., Garcia C.K., and Hobbs H.H. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat Genet 37 (2005) 161-165
64. Kotowski I.K., Pertsemlidis A., Luke A., Cooper R.S., Vega G.L., Cohen J.C., et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet 78 (2006) 410-422
65. Cohen J.C., Boerwinkle E., Mosley Jr. T.H., and Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354 (2006) 1264-1272
66. Kathiresan S. Myocardial Infarction Genetics Consortium. A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction. N Engl J Med 358 (2008) 2299-2300
67. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40 (2008) 161-169
68. Fernández-Fernández J.M., Tomás M., Vázquez E., Orio P., Latorre R., Sentí M., et al. Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension. J Clin Invest 113 (2004) 1032-1039
69. Sentí M., Fernández-Fernández J.M., Tomás M., Vázquez E., Elosua R., Marrugat J., et al. Protective effect of the KCNMB1 E65K genetic polymorphism against diastolic hypertension in aging women and its relevance to cardiovascular risk. Circ Res 97 (2005) 1360-1365
70. Zhao Q., Wang L., Yang W., Chen S., Huang J., Fan Z., et al. Interactions among genetic variants from contractile pathway of vascular smooth muscle cell in essential hypertension susceptibility of Chinese Han population. Pharmacogenet Genomics 18 (2008) 459-466
71. Nielsen T., Burgdorf K.S., Grarup N., Borch-Johnsen K., Hansen T., Jørgensen T., et al. The KCNMB1 Glu65Lys polymorphism associates with reduced systolic and diastolic blood pressure in the Inter99 study of 5729 Danes. J Hypertens 26 (2008) 2142-2146
72. Beitelshees A.L., Gong Y., Wang D., Schork N.J., Cooper-Dehoff R.M., Langaee T.Y., et al. INVEST Investigators KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). Pharmacogenet Genomics 17 (2007) 719-729
73. Kelley-Hedgepeth A., Peter I., Kip K., Montefusco M., Kogan S., Cox D., et al. The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with beta-blockade. J Hum Hypertens 22 (2008) 512-515
74. Lander E.S. The new genomics: global views of biology. Science 274 (1996) 536-539
75. Entrez SNP. Disponible en: www.ncbi.nlm.nih.gov/sites/entrez?db=snp
76. Manolio T.A., Brooks L.D., and Collins F.S. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118 (2008) 1590-1605
77. Helgadottir A., Thorleifsson G., Manolescu A., Gretarsdottir S., Blondal T., Jonasdottir A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (2007) 1491-1493
78. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 (2007) 1488-1491
79. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
80. Myocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with common single nucleotide polymorphisms, common copy number variants, and rare copy number variants. Nat Genet Epub (2009) Feb 8
81. Erdmaan J., Grobhennig A., Braund P.S., Konig I.R., Hengstenberg C., Hall A.S., et al. Novel susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet Epub (2009) Feb 8
82. Ozaki K., Sato H., Inoue K., Tsunoda T., Sakata Y., Mizuno H., et al. SNPs in BRAP associated with risk of myocardial infarction in Asian populations. Nat Genet Epub (2009) Feb 8
83. Gudbjasrtsson D.F., Bjornsdottier U.S., Halapir E., Helgadottir A., Sulem P., Jonsdottir G.M., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet Epub (2009) Feb 8
84. Tregouet D.A., Konig I.R., Erdmann J., Muteanu A., Braund P.S., Hall A.S., et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet Epub (2009) Feb 8
85. Kooner J.S., Chambers J.C., Aguilar-Salinas C.A., Hinds D.A., Hyde C.L., Warnes G.R., et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 40 (2008) 149-151
86. Pollin T.I., Damcott C.M., Shen H., Ott S.H., Shelton J., Horenstein R.B., et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322 (2008) 1702-1705
87. Wallace C., Newhouse S.J., Braund P., Zhang F., Tobin M., Falchi M., et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 82 (2008) 139-149
88. Sandhu M.S., Waterworth D.M., Debenham S.L., Wheeler E., Papadakis K., Zhao J.H., et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet 371 (2008) 483-491
89. Burkhardt R., Kenny E.E., Lowe J.K., Birkeland A., Josowitz R., Noel M., et al. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arterioscler Thromb Vasc Biol 28 (2008) 2078-2084
90. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40 (2008) 161-169
91. Kathiresan S., Melander O., Guiducci C., Surti A., Burtt N.P., Rieder M.J., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40 (2008) 189-197
92. Sabatti C., Service S.K., Hartikainen A.L., Pouta A., Ripatti S., Brodsky J., et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41 (2009) 35-46
93. Kathiresan S., Willer C.J., Peloso G.M., Demissie S., Musunuru K., Schadt E.E., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41 (2009) 56-65
94. Aulchenko Y.S., Ripatti S., Lindqvist I., Boomsma D., Heid I.M., Pramstaller P.P., et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41 (2009) 47-55
95. WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
96. Meigs J.B., Manning A.K., Fox C.S., Florez J.C., Liu C., Cupples L.A., et al. Genome-wide association with diabetes-related traits in the Framingham Heart Study. BMC Med Genet 8 Suppl 1 (2007) S16
97. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1341
98. Salonen J.T., Uimari P., Aalto J.M., Pirskanen M., Kaikkonen J., Todorova B., et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet 81 (2007) 338-345
99. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., De Bakker P.I., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
100. Steinthorsdottir V., Thorleifsson G., Reynisdottir I., Benediktsson R., Jonsdottir T., Walters G.B., et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 39 (2007) 770-775
101. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007) 1341-1345
102. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445 (2007) 881-885
103. Timpson N.J., Lindgren C.M., Weedon M.N., Randall J., Ouwehand W.H., Strachan D.P., et al. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome wide association data. Diabetes 58 (2009) 505-510
104. Zeggini E., Scott L.J., Saxena R., Voight B.F., Marchini J.L., Hu T., et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40 (2008) 638-645
105. Bierut L.J., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16 (2007) 24-35
106. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452 (2008) 638-642
107. Fox C.S., Heard-Costa N., Cupples L.A., Dupuis J., Vasan R.S., and Atwood L.D. Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project. BMC Med Genet 8 Suppl 1 (2007) S18
108. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 (2007) 889-894
109. Scuteri A., Sanna S., Chen W.M., Uda M., Albai G., Strait J., et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3 (2007) e115
110. Loos R.J., Lindgren C.M., Li S., Wheeler E., Zhao J.H., Prokopenko I., et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 40 (2008) 768-775
111. Willer C.J., Speliotes E.K., Loos R.J., Li S., Lindgren C.M., Heid I.M., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41 (2009) 25-34
112. Thorleifsson G., Walters G.B., Gudbjartsson D.F., Steinthorsdottir V., Sulem P., Helgadottir A., et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41 (2009) 18-24
113. Pablos J.L., Santiago B., Galindo M., Torres C., Brehmer M.T., Blanco F.J., et al. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J. Immun 170 (2003) 2147-2152
114. D'Agostino Jr. R.B., Grundy S., Sullivan L.M., Wilson P., and CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
115. Morrison A.C., Bare L.A., Chambless L.E., Ellis S.G., Malloy M., Kane J.P., et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 166 (2007) 28-35
116. Kathiresan S., Melander O., Anevski D., Guiducci C., Burtt N.P., Roos C., et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358 (2008) 1240-1249
117. Paynter N.P., Chasman D.I., Buring J.E., Shiffman D., Cook N.R., and Ridker P.M. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med 150 (2009) 65-72
118. Costet P., Krempf M., and Cariou B. PCSK9 and LDL cholesterol: unravelling the target to design the bullet. Trends Biochem Sci 33 (2008) 426-434
119. FDA Clears Genetic Lab Test for Warfarin Sensitivity Disponible en: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01701.html
120. Higashi M.K., Veenstra D.L., Kondo L.M., Wittkowsky A.K., Srinouanprachanh S.L., Farin F.M., et al. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 287 (2002) 1690-1698
121. Aithal G.P., Day C.P., Kesteven P.J., and Daly A.K. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353 (1999) 717-719
122. Schwarz U.I., Ritchie M.D., Bradford Y., Li C., Dudek S.M., Frye-Anderson A., et al. Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med 358 (2008) 999-1008
123. Rieder M.J., Reiner A.P., Gage B.F., Nickerson D.A., Eby C.S., McLeod H.L., et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 352 (2005) 2285-2293
124. Mega J.L., Close S.L., Wiviott S.D., Shen L., Hackett R.D., Brandt J.T., et al. Cytrochrome P-450 polymorphisms and response to clopidogrel. N Engl J Med 360 (2009) 354-362
125. Simon T., Verstuyft C., Mary-Krause M., Quteineh L., Drouet E., Méneveau N., et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 360 (2009) 363-375
126. Smith G.D., and Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33 (2004) 30-42
127. Zacho J., Tybajaerg-Hansen A., Jensen J.S., Grande P., Sillesen H., and Nordestgaard B.G. Genetically elevated C-Reactive protein and ischemic vascular disease. N Engl J Med 359 (2008) 1897-1908
128. Schunkert H., and Samani NJ. Elevated C-Reactive protein in atherosclerosis. Chicken or Egg?. N Engl J Med 359 (2008) 1953-1955
129. Kaput J., Ordovas J.M., Ferguson L., Van Ommen B., Rodriguez R.L., Allen L., et al. The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr 94 (2005) 623-632
130. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., et al. Global variation in copy number in the human genome. Nature 444 (2006) 444-454
131. Melzer D., Hogarth S., Liddell K., Ling T., Sanderson S., and Zimmern R.L. Genetic test for common diseases: new insights, old concerns. BMJ 336 (2008) 590-593
132. Wray N.R., Goddard M.E., and Visscher P.M. Prediction of individual genetic risk to disease from genome-wide association Studies. Gen Res 17 (2007) 1520-1528
133. 1000 Genomes. Disponible en: www.1000genomes.org
134. Scheuner M.T., Sieverding P., and Shekelle P.G. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 299 (2008) 1320-1334
135. Clayton E.W. Ethical, legal, and social implications of genomic medicine. N Engl J Med 349 (2003) 562-569